SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-19-000045
Filing Date
2019-08-14
Accepted
2019-08-14 16:24:41
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20190630x10q.htm 10-Q 1028456
2 EXHIBIT 31.1 sls20190630ex311.htm EX-31.1 11679
3 EXHIBIT 31.2 sls20190630ex312.htm EX-31.2 11633
4 EXHIBIT 32.1 sls20190630ex321.htm EX-32.1 10924
11 sellas-logoa09.jpg GRAPHIC 30719
  Complete submission text file 0001390478-19-000045.txt   5147657

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20190630.xml EX-101.INS 979420
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20190630.xsd EX-101.SCH 47137
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20190630_cal.xml EX-101.CAL 63754
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20190630_def.xml EX-101.DEF 180375
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20190630_lab.xml EX-101.LAB 540354
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20190630_pre.xml EX-101.PRE 318984
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 191026778
SIC: 2834 Pharmaceutical Preparations